China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
China
· Delayed Price · Currency is CNY 19.57
+0.16 (0.82%)
Apr 3, 2025, 2:45 PM CST
SHA:600062 Revenue
In the year 2024, China Resources Double-Crane Pharmaceutical had annual revenue of 11.21B CNY with 9.68% growth. China Resources Double-Crane Pharmaceutical had revenue of 2.66B in the quarter ending December 31, 2024, a decrease of -6.93%.
Revenue
11.21B
Revenue Growth
-0.87%
P/S Ratio
1.78
Revenue / Employee
913.82K
Employees
12,269
Market Cap
19.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.21B | 989.49M | 9.68% |
| Dec 31, 2023 | 10.22B | 596.82M | 6.20% |
| Dec 31, 2022 | 9.63B | 513.80M | 5.64% |
| Dec 31, 2021 | 9.11B | 607.58M | 7.14% |
| Dec 31, 2020 | 8.50B | -877.05M | -9.35% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |
| Shanghai United Imaging Healthcare | 10.30B |
| Sichuan Biokin Pharmaceutical | 5.82B |